<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2020-10-07" version="225">
<accession>Q9Y6K9</accession>
<accession>Q7LBY6</accession>
<accession>Q7Z7F1</accession>
<name>NEMO_HUMAN</name>
<protein>
<recommendedName>
<fullName>NF-kappa-B essential modulator</fullName>
<shortName>NEMO</shortName>
</recommendedName>
<alternativeName>
<fullName>FIP-3</fullName>
</alternativeName>
<alternativeName>
<fullName>IkB kinase-associated protein 1</fullName>
<shortName>IKKAP1</shortName>
</alternativeName>
<alternativeName>
<fullName>Inhibitor of nuclear factor kappa-B kinase subunit gamma</fullName>
<shortName>I-kappa-B kinase subunit gamma</shortName>
<shortName>IKK-gamma</shortName>
<shortName>IKKG</shortName>
<shortName>IkB kinase subunit gamma</shortName>
</alternativeName>
<alternativeName>
<fullName>NF-kappa-B essential modifier</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IKBKG</name>
<name type="synonym">FIP3</name>
<name type="synonym">NEMO</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="1042" last="1047">
<title>Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.</title>
<authorList>
<person name="Li Y."/>
<person name="Kang J."/>
<person name="Friedman J."/>
<person name="Tarassishin L."/>
<person name="Ye J."/>
<person name="Kovalenko A."/>
<person name="Wallach D."/>
<person name="Horwitz M.S."/>
</authorList>
<dbReference type="PubMed" id="9927690"/>
<dbReference type="DOI" id="10.1073/pnas.96.3.1042"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="J. Biomed. Sci." volume="6" first="115" last="120">
<title>Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28.</title>
<authorList>
<person name="Jin D.-Y."/>
<person name="Jeang K.-T."/>
</authorList>
<dbReference type="PubMed" id="10087442"/>
<dbReference type="DOI" id="10.1159/000025378"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Nature" volume="395" first="297" last="300">
<title>IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.</title>
<authorList>
<person name="Rothwarf D.M."/>
<person name="Zandi E."/>
<person name="Natoli G."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="9751060"/>
<dbReference type="DOI" id="10.1038/26261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Nature" volume="405" first="466" last="472">
<title>Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti.</title>
<authorList>
<person name="Smahi A."/>
<person name="Courtois G."/>
<person name="Vabres P."/>
<person name="Yamaoka S."/>
<person name="Heuertz S."/>
<person name="Munnich A."/>
<person name="Israel A."/>
<person name="Heiss N.S."/>
<person name="Klauck S.M."/>
<person name="Kioschis P."/>
<person name="Wiemann S."/>
<person name="Poustka A."/>
<person name="Esposito T."/>
<person name="Bardaro T."/>
<person name="Gianfrancesco F."/>
<person name="Ciccodicola A."/>
<person name="D'Urso M."/>
<person name="Woffendin H."/>
<person name="Jakins T."/>
<person name="Donnai D."/>
<person name="Stewart H."/>
<person name="Kenwrick S.J."/>
<person name="Aradhya S."/>
<person name="Yamagata T."/>
<person name="Levy M."/>
<person name="Lewis R.A."/>
<person name="Nelson D.L."/>
</authorList>
<dbReference type="PubMed" id="10839543"/>
<dbReference type="DOI" id="10.1038/35013114"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT IP VAL-407</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="275" first="223" last="227">
<title>cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs.</title>
<authorList>
<person name="Ye Z."/>
<person name="Connor J.R."/>
</authorList>
<dbReference type="PubMed" id="10944468"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3282"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Astrocytoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2002-05" db="EMBL/GenBank/DDBJ databases">
<title>Ikbkg gene modulates the herpes virus susceptibility in mice.</title>
<authorList>
<person name="Perelygin A.A."/>
<person name="Perelygina L.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
<tissue>Placenta</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="1526" last="1538">
<title>IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex.</title>
<authorList>
<person name="Mercurio F."/>
<person name="Murray B.W."/>
<person name="Shevchenko A."/>
<person name="Bennett B.L."/>
<person name="Young D.B."/>
<person name="Li J.W."/>
<person name="Pascual G."/>
<person name="Motiwala A."/>
<person name="Zhu H."/>
<person name="Mann M."/>
<person name="Manning A.M."/>
</authorList>
<dbReference type="PubMed" id="9891086"/>
<dbReference type="DOI" id="10.1128/mcb.19.2.1526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 51-419 (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 144-159</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17402" last="17405">
<title>Role of adapter function in oncoprotein-mediated activation of NF-kappaB: human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma.</title>
<authorList>
<person name="Jin D.-Y."/>
<person name="Giordano V."/>
<person name="Kibler K.V."/>
<person name="Nakano H."/>
<person name="Jeang K.-T."/>
</authorList>
<dbReference type="PubMed" id="10364167"/>
<dbReference type="DOI" id="10.1074/jbc.274.25.17402"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX-1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="5198" last="5203">
<title>Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein.</title>
<authorList>
<person name="Xiao G."/>
<person name="Sun S.C."/>
</authorList>
<dbReference type="PubMed" id="11064457"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203894"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX-1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="FEBS Lett." volume="498" first="93" last="97">
<title>Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.</title>
<authorList>
<person name="Klinkenberg M."/>
<person name="Van Huffel S."/>
<person name="Heyninck K."/>
<person name="Beyaert R."/>
</authorList>
<dbReference type="PubMed" id="11389905"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)02504-2"/>
</citation>
<scope>INTERACTION WITH TNFAIP3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="FEBS Lett." volume="499" first="133" last="136">
<title>CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.</title>
<authorList>
<person name="Hong X."/>
<person name="Xu L.-G."/>
<person name="Li X."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="11418127"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)02535-2"/>
</citation>
<scope>INTERACTION WITH COPS3</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="4494" last="4500">
<title>Role of ikkgamma/nemo in assembly of the IkappaB kinase complex.</title>
<authorList>
<person name="Li X.-H."/>
<person name="Fang X."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="11080499"/>
<dbReference type="DOI" id="10.1074/jbc.m008353200"/>
</citation>
<scope>SUBUNIT OF THE IKK COMPLEX</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37029" last="37036">
<title>Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.</title>
<authorList>
<person name="Chariot A."/>
<person name="Leonardi A."/>
<person name="Muller J."/>
<person name="Bonif M."/>
<person name="Brown K."/>
<person name="Siebenlist U."/>
</authorList>
<dbReference type="PubMed" id="12133833"/>
<dbReference type="DOI" id="10.1074/jbc.m205069200"/>
</citation>
<scope>INTERACTION WITH TANK AND IKBKB</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/mcb.22.10.3549-3561.2002"/>
</citation>
<scope>SUBUNIT OF A COMPLEX CONTAINING CREBBP; NCOA2; NCOA3; IKKA AND IKKB</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Cell" volume="115" first="565" last="576">
<title>Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.</title>
<authorList>
<person name="Huang T.T."/>
<person name="Wuerzberger-Davis S.M."/>
<person name="Wu Z.H."/>
<person name="Miyamoto S."/>
</authorList>
<dbReference type="PubMed" id="14651848"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00895-x"/>
</citation>
<scope>SUMOYLATION AT LYS-277 AND LYS-309</scope>
<scope>UBIQUITINATION AT LYS-277 AND LYS-309</scope>
<scope>MUTAGENESIS OF LYS-277 AND LYS-309</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT EDAID1 ARG-417</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="19642" last="19648">
<title>In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase.</title>
<authorList>
<person name="Carter R.S."/>
<person name="Pennington K.N."/>
<person name="Ungurait B.J."/>
<person name="Ballard D.W."/>
</authorList>
<dbReference type="PubMed" id="12657630"/>
<dbReference type="DOI" id="10.1074/jbc.m301705200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-31; SER-43 AND SER-376</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="2029" last="2041">
<title>Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.</title>
<authorList>
<person name="Tegethoff S."/>
<person name="Behlke J."/>
<person name="Scheidereit C."/>
</authorList>
<dbReference type="PubMed" id="12612076"/>
<dbReference type="DOI" id="10.1128/mcb.23.6.2029-2041.2003"/>
</citation>
<scope>SELF-ASSOCIATION</scope>
<scope>COMPOSITION OF THE IKK COMPLEX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Nature" volume="424" first="801" last="805">
<title>The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.</title>
<authorList>
<person name="Kovalenko A."/>
<person name="Chable-Bessia C."/>
<person name="Cantarella G."/>
<person name="Israeel A."/>
<person name="Wallach D."/>
<person name="Courtois G."/>
</authorList>
<dbReference type="PubMed" id="12917691"/>
<dbReference type="DOI" id="10.1038/nature01802"/>
</citation>
<scope>INTERACTION WITH CYLD</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="Curr. Biol." volume="14" first="2217" last="2227">
<title>The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.</title>
<authorList>
<person name="Abbott D.W."/>
<person name="Wilkins A."/>
<person name="Asara J.M."/>
<person name="Cantley L.C."/>
</authorList>
<dbReference type="PubMed" id="15620648"/>
<dbReference type="DOI" id="10.1016/j.cub.2004.12.032"/>
</citation>
<scope>UBIQUITINATION AT LYS-285</scope>
<scope>MUTAGENESIS OF LYS-115; LYS-224; LYS-285 AND LYS-399</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="16847" last="16853">
<title>ZNF216 is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.</title>
<authorList>
<person name="Huang J."/>
<person name="Teng L."/>
<person name="Li L."/>
<person name="Liu T."/>
<person name="Li L."/>
<person name="Chen D."/>
<person name="Xu L.-G."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14754897"/>
<dbReference type="DOI" id="10.1074/jbc.m309491200"/>
</citation>
<scope>INTERACTION WITH ZFAND5</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51897" last="51907">
<title>PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.</title>
<authorList>
<person name="Bruey J.-M."/>
<person name="Bruey-Sedano N."/>
<person name="Newman R."/>
<person name="Chandler S."/>
<person name="Stehlik C."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="15456791"/>
<dbReference type="DOI" id="10.1074/jbc.m406741200"/>
</citation>
<scope>INTERACTION WITH NALP2</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="289" last="301">
<title>The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.</title>
<authorList>
<person name="Sun L."/>
<person name="Deng L."/>
<person name="Ea C.-K."/>
<person name="Xia Z.-P."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="15125833"/>
<dbReference type="DOI" id="10.1016/s1097-2765(04)00236-9"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="Nature" volume="427" first="167" last="171">
<title>Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.</title>
<authorList>
<person name="Zhou H."/>
<person name="Wertz I."/>
<person name="O'Rourke K."/>
<person name="Ultsch M."/>
<person name="Seshagiri S."/>
<person name="Eby M."/>
<person name="Xiao W."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="14695475"/>
<dbReference type="DOI" id="10.1038/nature02273"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION AT LYS-399</scope>
<scope>MUTAGENESIS OF LYS-399</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Cell" volume="123" first="1079" last="1092">
<title>PIDD mediates NF-kappaB activation in response to DNA damage.</title>
<authorList>
<person name="Janssens S."/>
<person name="Tinel A."/>
<person name="Lippens S."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16360037"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.09.036"/>
</citation>
<scope>INTERACTION WITH PIDD1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="398" last="406">
<title>Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation.</title>
<authorList>
<person name="Wu C.J."/>
<person name="Conze D.B."/>
<person name="Li T."/>
<person name="Srinivasula S.M."/>
<person name="Ashwell J.D."/>
</authorList>
<dbReference type="PubMed" id="16547522"/>
<dbReference type="DOI" id="10.1038/ncb1384"/>
</citation>
<scope>UBIQUITIN-BINDING</scope>
<scope>MUTAGENESIS OF LEU-329</scope>
<scope>CHARACTERIZATION OF VARIANT EDAID1 ASN-311</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="424" last="424">
<authorList>
<person name="Wu C.J."/>
<person name="Conze D.B."/>
<person name="Li T."/>
<person name="Srinivasula S.M."/>
<person name="Ashwell J.D."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:16547522</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Science" volume="311" first="1141" last="1146">
<title>Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.</title>
<authorList>
<person name="Wu Z.H."/>
<person name="Shi Y."/>
<person name="Tibbetts R.S."/>
<person name="Miyamoto S."/>
</authorList>
<dbReference type="PubMed" id="16497931"/>
<dbReference type="DOI" id="10.1126/science.1121513"/>
</citation>
<scope>INTERACTION WITH ATM</scope>
<scope>PHOSPHORYLATION AT SER-85</scope>
<scope>MUTAGENESIS OF SER-85</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="4102" last="4112">
<title>Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.</title>
<authorList>
<person name="Lamothe B."/>
<person name="Besse A."/>
<person name="Campos A.D."/>
<person name="Webster W.K."/>
<person name="Wu H."/>
<person name="Darnay B.G."/>
</authorList>
<dbReference type="PubMed" id="17135271"/>
<dbReference type="DOI" id="10.1074/jbc.m609503200"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="367" first="103" last="108">
<title>Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347.</title>
<authorList>
<person name="Herscovitch M."/>
<person name="Comb W."/>
<person name="Ennis T."/>
<person name="Coleman K."/>
<person name="Yong S."/>
<person name="Armstead B."/>
<person name="Kalaitzidis D."/>
<person name="Chandani S."/>
<person name="Gilmore T.D."/>
</authorList>
<dbReference type="PubMed" id="18164680"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.12.123"/>
</citation>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="373" last="383">
<title>A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.</title>
<authorList>
<person name="Hasegawa M."/>
<person name="Fujimoto Y."/>
<person name="Lucas P.C."/>
<person name="Nakano H."/>
<person name="Fukase K."/>
<person name="Nunez G."/>
<person name="Inohara N."/>
</authorList>
<dbReference type="PubMed" id="18079694"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601962"/>
</citation>
<scope>INTERACTION WITH RIPK2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="76" last="86">
<title>Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.</title>
<authorList>
<person name="Palkowitsch L."/>
<person name="Leidner J."/>
<person name="Ghosh S."/>
<person name="Marienfeld R.B."/>
</authorList>
<dbReference type="PubMed" id="17977820"/>
<dbReference type="DOI" id="10.1074/jbc.m708856200"/>
</citation>
<scope>INTERACTION WITH IKBKB</scope>
<scope>PHOSPHORYLATION AT SER-68</scope>
<scope>MUTAGENESIS OF SER-68</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="2902" last="2907">
<title>The zinc finger of NEMO is a functional ubiquitin-binding domain.</title>
<authorList>
<person name="Cordier F."/>
<person name="Grubisha O."/>
<person name="Traincard F."/>
<person name="Veron M."/>
<person name="Delepierre M."/>
<person name="Agou F."/>
</authorList>
<dbReference type="PubMed" id="19033441"/>
<dbReference type="DOI" id="10.1074/jbc.m806655200"/>
</citation>
<scope>UBIQUITIN-BINDING</scope>
<scope>MUTAGENESIS OF VAL-414 AND MET-415</scope>
<scope>CHARACTERIZATION OF VARIANT IP VAL-407</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="315" last="325">
<title>Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3.</title>
<authorList>
<person name="Zeng W."/>
<person name="Xu M."/>
<person name="Liu S."/>
<person name="Sun L."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="19854139"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.09.037"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN LEUCINE-ZIPPER AND C2HC-TYPE ZINC-FINGER</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="123" last="132">
<title>Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.</title>
<authorList>
<person name="Tokunaga F."/>
<person name="Sakata S."/>
<person name="Saeki Y."/>
<person name="Satomi Y."/>
<person name="Kirisako T."/>
<person name="Kamei K."/>
<person name="Nakagawa T."/>
<person name="Kato M."/>
<person name="Murata S."/>
<person name="Yamaoka S."/>
<person name="Yamamoto M."/>
<person name="Akira S."/>
<person name="Takao T."/>
<person name="Tanaka K."/>
<person name="Iwai K."/>
</authorList>
<dbReference type="PubMed" id="19136968"/>
<dbReference type="DOI" id="10.1038/ncb1821"/>
</citation>
<scope>UBIQUITINATION AT LYS-285 AND LYS-309</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="395" first="89" last="104">
<title>DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.</title>
<authorList>
<person name="Grubisha O."/>
<person name="Kaminska M."/>
<person name="Duquerroy S."/>
<person name="Fontan E."/>
<person name="Cordier F."/>
<person name="Haouz A."/>
<person name="Raynal B."/>
<person name="Chiaravalli J."/>
<person name="Delepierre M."/>
<person name="Israel A."/>
<person name="Veron M."/>
<person name="Agou F."/>
</authorList>
<dbReference type="PubMed" id="19854204"/>
<dbReference type="DOI" id="10.1016/j.jmb.2009.10.018"/>
</citation>
<scope>MUTAGENESIS OF GLU-296; PHE-312; LEU-329 AND LEU-336</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD33 ALA-315 AND PRO-323</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="66" last="73">
<title>A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response.</title>
<authorList>
<person name="Ashida H."/>
<person name="Kim M."/>
<person name="Schmidt-Supprian M."/>
<person name="Ma A."/>
<person name="Ogawa M."/>
<person name="Sasakawa C."/>
</authorList>
<dbReference type="PubMed" id="20010814"/>
<dbReference type="DOI" id="10.1038/ncb2006"/>
</citation>
<scope>INTERACTION WITH SHIGELLA FLEXNERI IPAH9.8 (MICROBIAL INFECTION)</scope>
<scope>UBIQUITINATION AT LYS-309 AND LYS-321</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="15856" last="15861">
<title>Polyubiquitin conjugation to NEMO by tripartite motif protein 23 (TRIM23) is critical in antiviral defense.</title>
<authorList>
<person name="Arimoto K."/>
<person name="Funami K."/>
<person name="Saeki Y."/>
<person name="Tanaka K."/>
<person name="Okawa K."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Murakami Y."/>
<person name="Shimotohno K."/>
</authorList>
<dbReference type="PubMed" id="20724660"/>
<dbReference type="DOI" id="10.1073/pnas.1004621107"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="Carcinogenesis" volume="32" first="995" last="1004">
<title>TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers.</title>
<authorList>
<person name="Noguchi K."/>
<person name="Okumura F."/>
<person name="Takahashi N."/>
<person name="Kataoka A."/>
<person name="Kamiyama T."/>
<person name="Todo S."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="21474709"/>
<dbReference type="DOI" id="10.1093/carcin/bgr068"/>
</citation>
<scope>NEDDYLATION BY TRIM40</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="J. Exp. Med." volume="208" first="1215" last="1228">
<title>Polyubiquitin binding to ABIN1 is required to prevent autoimmunity.</title>
<authorList>
<person name="Nanda S.K."/>
<person name="Venigalla R.K."/>
<person name="Ordureau A."/>
<person name="Patterson-Kane J.C."/>
<person name="Powell D.W."/>
<person name="Toth R."/>
<person name="Arthur J.S."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="21606507"/>
<dbReference type="DOI" id="10.1084/jem.20102177"/>
</citation>
<scope>UBIQUITIN-BINDING</scope>
<scope>CHARACTERIZATION OF VARIANT EDAID1 ASN-311</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Mol. Cell" volume="44" first="559" last="571">
<title>Direct, noncatalytic mechanism of IKK inhibition by A20.</title>
<authorList>
<person name="Skaug B."/>
<person name="Chen J."/>
<person name="Du F."/>
<person name="He J."/>
<person name="Ma A."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="22099304"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.09.015"/>
</citation>
<scope>INTERACTION WITH TNFAIP3</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Nature" volume="471" first="591" last="596">
<title>Linear ubiquitination prevents inflammation and regulates immune signalling.</title>
<authorList>
<person name="Gerlach B."/>
<person name="Cordier S.M."/>
<person name="Schmukle A.C."/>
<person name="Emmerich C.H."/>
<person name="Rieser E."/>
<person name="Haas T.L."/>
<person name="Webb A.I."/>
<person name="Rickard J.A."/>
<person name="Anderton H."/>
<person name="Wong W.W."/>
<person name="Nachbur U."/>
<person name="Gangoda L."/>
<person name="Warnken U."/>
<person name="Purcell A.W."/>
<person name="Silke J."/>
<person name="Walczak H."/>
</authorList>
<dbReference type="PubMed" id="21455173"/>
<dbReference type="DOI" id="10.1038/nature09816"/>
</citation>
<scope>UBIQUITINATION BY THE LUBAC COMPLEX</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="Nature" volume="471" first="633" last="636">
<title>SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex.</title>
<authorList>
<person name="Tokunaga F."/>
<person name="Nakagawa T."/>
<person name="Nakahara M."/>
<person name="Saeki Y."/>
<person name="Taniguchi M."/>
<person name="Sakata S."/>
<person name="Tanaka K."/>
<person name="Nakano H."/>
<person name="Iwai K."/>
</authorList>
<dbReference type="PubMed" id="21455180"/>
<dbReference type="DOI" id="10.1038/nature09815"/>
</citation>
<scope>UBIQUITINATION BY THE LUBAC COMPLEX</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2011" name="Nature" volume="471" first="637" last="641">
<title>SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis.</title>
<authorList>
<person name="Ikeda F."/>
<person name="Deribe Y.L."/>
<person name="Skanland S.S."/>
<person name="Stieglitz B."/>
<person name="Grabbe C."/>
<person name="Franz-Wachtel M."/>
<person name="van Wijk S.J."/>
<person name="Goswami P."/>
<person name="Nagy V."/>
<person name="Terzic J."/>
<person name="Tokunaga F."/>
<person name="Androulidaki A."/>
<person name="Nakagawa T."/>
<person name="Pasparakis M."/>
<person name="Iwai K."/>
<person name="Sundberg J.P."/>
<person name="Schaefer L."/>
<person name="Rittinger K."/>
<person name="Macek B."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="21455181"/>
<dbReference type="DOI" id="10.1038/nature09814"/>
</citation>
<scope>UBIQUITINATION AT LYS-277; LYS-285; LYS-309; LYS-326; LYS-111; LYS-143; LYS-226; LYS-246; LYS-264; LYS-292 AND LYS-302 BY THE LUBAC COMPLEX</scope>
<scope>UBIQUITINATION AT LYS-139 AND LYS-283</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2012" name="Cell. Microbiol." volume="14" first="1568" last="1583">
<title>NLRP10 enhances Shigella-induced pro-inflammatory responses.</title>
<authorList>
<person name="Lautz K."/>
<person name="Damm A."/>
<person name="Menning M."/>
<person name="Wenger J."/>
<person name="Adam A.C."/>
<person name="Zigrino P."/>
<person name="Kremmer E."/>
<person name="Kufer T.A."/>
</authorList>
<dbReference type="PubMed" id="22672233"/>
<dbReference type="DOI" id="10.1111/j.1462-5822.2012.01822.x"/>
</citation>
<scope>INTERACTION WITH NLRP10</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="724" last="733">
<title>IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Zhou A.Y."/>
<person name="Shen R.R."/>
<person name="Kim E."/>
<person name="Lock Y.J."/>
<person name="Xu M."/>
<person name="Chen Z.J."/>
<person name="Hahn W.C."/>
</authorList>
<dbReference type="PubMed" id="23453969"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.031"/>
</citation>
<scope>INTERACTION WITH IKBKE</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2013" name="Protein Expr. Purif." volume="92" first="48" last="53">
<title>Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification.</title>
<authorList>
<person name="Jackson S.S."/>
<person name="Coughlin E.E."/>
<person name="Coon J.J."/>
<person name="Miyamoto S."/>
</authorList>
<dbReference type="PubMed" id="24012789"/>
<dbReference type="DOI" id="10.1016/j.pep.2013.08.020"/>
</citation>
<scope>PHOSPHORYLATION AT SER-387</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="56">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="2343" last="2354">
<title>IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1).</title>
<authorList>
<person name="Zheng C."/>
<person name="Zheng Z."/>
<person name="Zhang Z."/>
<person name="Meng J."/>
<person name="Liu Y."/>
<person name="Ke X."/>
<person name="Hu Q."/>
<person name="Wang H."/>
</authorList>
<dbReference type="PubMed" id="26334375"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2015.08.018"/>
</citation>
<scope>INTERACTION WITH IFIT5</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="13372" last="13385">
<title>TRAF family member-associated NF-kappaB activator (TANK) inhibits genotoxic nuclear factor kappaB activation by facilitating deubiquitinase USP10-dependent deubiquitination of TRAF6 ligase.</title>
<authorList>
<person name="Wang W."/>
<person name="Huang X."/>
<person name="Xin H.B."/>
<person name="Fu M."/>
<person name="Xue A."/>
<person name="Wu Z.H."/>
</authorList>
<dbReference type="PubMed" id="25861989"/>
<dbReference type="DOI" id="10.1074/jbc.m115.643767"/>
</citation>
<scope>INTERACTION WITH TANK; USP10 AND ZC3H12A</scope>
<scope>DEUBIQUITINATION BY USP10</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="2173" last="2181">
<title>Dimer of arfaptin 2 regulates NF-kappaB signaling by interacting with IKKbeta/NEMO and inhibiting IKKbeta kinase activity.</title>
<authorList>
<person name="You D.J."/>
<person name="Park C.R."/>
<person name="Furlong M."/>
<person name="Koo O."/>
<person name="Lee C."/>
<person name="Ahn C."/>
<person name="Seong J.Y."/>
<person name="Hwang J.I."/>
</authorList>
<dbReference type="PubMed" id="26296658"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2015.08.012"/>
</citation>
<scope>INTERACTION WITH ARFIP2</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Molluscum contagiosum virus protein MC005 inhibits NF-kappaB activation by targeting NEMO-regulated IkappaB kinase activation.</title>
<authorList>
<person name="Brady G."/>
<person name="Haas D.A."/>
<person name="Farrell P.J."/>
<person name="Pichlmair A."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="28490597"/>
<dbReference type="DOI" id="10.1128/jvi.00545-17"/>
</citation>
<scope>INTERACTION WITH MOLLUSCUM CONTAGIOSUM VIRUS PROTEIN MC005 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="377" first="1419" last="1432">
<title>Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.</title>
<authorList>
<person name="Cordier F."/>
<person name="Vinolo E."/>
<person name="Veron M."/>
<person name="Delepierre M."/>
<person name="Agou F."/>
</authorList>
<dbReference type="PubMed" id="18313693"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.01.048"/>
</citation>
<scope>STRUCTURE BY NMR OF 394-419 OF WILD-TYPE AND MUTANT PHE-417</scope>
<scope>DOMAIN ZINC-FINGER</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2008" name="Structure" volume="16" first="798" last="808">
<title>Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.</title>
<authorList>
<person name="Rushe M."/>
<person name="Silvian L."/>
<person name="Bixler S."/>
<person name="Chen L.L."/>
<person name="Cheung A."/>
<person name="Bowes S."/>
<person name="Cuervo H."/>
<person name="Berkowitz S."/>
<person name="Zheng T."/>
<person name="Guckian K."/>
<person name="Pellegrini M."/>
<person name="Lugovskoy A."/>
</authorList>
<dbReference type="PubMed" id="18462684"/>
<dbReference type="DOI" id="10.1016/j.str.2008.02.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 44-111 IN COMPLEX WITH CHUK AND IKBKB</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2009" name="Mol. Cell" volume="33" first="602" last="615">
<title>Structural basis for recognition of diubiquitins by NEMO.</title>
<authorList>
<person name="Lo Y.C."/>
<person name="Lin S.C."/>
<person name="Rospigliosi C.C."/>
<person name="Conze D.B."/>
<person name="Wu C.J."/>
<person name="Ashwell J.D."/>
<person name="Eliezer D."/>
<person name="Wu H."/>
</authorList>
<dbReference type="PubMed" id="19185524"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.01.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 246-337</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>MUTAGENESIS OF VAL-300; LEU-301; GLN-304; ILE-307; TYR-308; PHE-312; GLN-313 AND GLN-317</scope>
<scope>CHARACTERIZATION OF VARIANT EDAID1 ASN-311</scope>
<scope>CHARACTERIZATION OF VARIANT IMD33 ALA-315</scope>
<scope>CHARACTERIZATION OF VARIANTS GLN-319 AND IP PRO-323</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="67" first="1555" last="1562">
<title>A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).</title>
<authorList>
<person name="Zonana J."/>
<person name="Elder M.E."/>
<person name="Schneider L.C."/>
<person name="Orlow S.J."/>
<person name="Moss C."/>
<person name="Golabi M."/>
<person name="Shapira S.K."/>
<person name="Farndon P.A."/>
<person name="Wara D.W."/>
<person name="Emmal S.A."/>
<person name="Ferguson B.M."/>
</authorList>
<dbReference type="PubMed" id="11047757"/>
<dbReference type="DOI" id="10.1086/316914"/>
</citation>
<scope>VARIANTS EDAID1 ARG-417 AND PHE-417</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="2171" last="2179">
<title>A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.</title>
<authorList>
<person name="Aradhya S."/>
<person name="Woffendin H."/>
<person name="Jakins T."/>
<person name="Bardaro T."/>
<person name="Esposito T."/>
<person name="Smahi A."/>
<person name="Shaw C."/>
<person name="Levy M."/>
<person name="Munnich A."/>
<person name="D'Urso M."/>
<person name="Lewis R.A."/>
<person name="Kenwrick S."/>
<person name="Nelson D.L."/>
</authorList>
<dbReference type="PubMed" id="11590134"/>
<dbReference type="DOI" id="10.1093/hmg/10.19.2171"/>
</citation>
<scope>VARIANTS IP LYS-57 AND VAL-407</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="277" last="285">
<title>X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa B signaling.</title>
<authorList>
<person name="Doeffinger R."/>
<person name="Smahi A."/>
<person name="Bessia C."/>
<person name="Geissmann F."/>
<person name="Feinberg J."/>
<person name="Durandy A."/>
<person name="Bodemer C."/>
<person name="Kenwrick S.J."/>
<person name="Dupuis-Girod S."/>
<person name="Blanche S."/>
<person name="Wood P."/>
<person name="Rabia S.H."/>
<person name="Headon D.J."/>
<person name="Overbeek P.A."/>
<person name="Le Deist F."/>
<person name="Holland S.M."/>
<person name="Belani K."/>
<person name="Kumararatne D.S."/>
<person name="Fischer A."/>
<person name="Shapiro R."/>
<person name="Conley M.E."/>
<person name="Reimund E."/>
<person name="Kalhoff H."/>
<person name="Abinun M."/>
<person name="Munnich A."/>
<person name="Israael A."/>
<person name="Courtois G."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="11242109"/>
<dbReference type="DOI" id="10.1038/85837"/>
</citation>
<scope>INVOLVEMENT IN EDAID1</scope>
<scope>VARIANTS EDAID1 PRO-175; PRO-227; GLY-288; ASN-311; ARG-417 AND PHE-417</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2001" name="Nat. Immunol." volume="2" first="223" last="228">
<title>Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.</title>
<authorList>
<person name="Jain A."/>
<person name="Ma C.A."/>
<person name="Liu S."/>
<person name="Brown M."/>
<person name="Cohen J."/>
<person name="Strober W."/>
</authorList>
<dbReference type="PubMed" id="11224521"/>
<dbReference type="DOI" id="10.1038/85277"/>
</citation>
<scope>VARIANTS EDAID1 VAL-406 AND ARG-417</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2002" name="J. Clin. Invest." volume="109" first="1501" last="1509">
<title>Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.</title>
<authorList>
<person name="Orange J.S."/>
<person name="Brodeur S.R."/>
<person name="Jain A."/>
<person name="Bonilla F.A."/>
<person name="Schneider L.C."/>
<person name="Kretschmer R."/>
<person name="Nurko S."/>
<person name="Rasmussen W.L."/>
<person name="Koehler J.R."/>
<person name="Gellis S.E."/>
<person name="Ferguson B.M."/>
<person name="Strominger J.L."/>
<person name="Zonana J."/>
<person name="Ramesh N."/>
<person name="Ballas Z.K."/>
<person name="Geha R.S."/>
</authorList>
<dbReference type="PubMed" id="12045264"/>
<dbReference type="DOI" id="10.1172/jci14858"/>
</citation>
<scope>VARIANTS EDAID1 ARG-153 AND ARG-417</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="1763" last="1773">
<title>Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.</title>
<authorList>
<person name="Fusco F."/>
<person name="Bardaro T."/>
<person name="Fimiani G."/>
<person name="Mercadante V."/>
<person name="Miano M.G."/>
<person name="Falco G."/>
<person name="Israeel A."/>
<person name="Courtois G."/>
<person name="D'Urso M."/>
<person name="Ursini M.V."/>
</authorList>
<dbReference type="PubMed" id="15229184"/>
<dbReference type="DOI" id="10.1093/hmg/ddh192"/>
</citation>
<scope>VARIANTS IP LYS-57; LYS-90 DEL AND TRP-123</scope>
<scope>VARIANT ASN-113</scope>
<scope>CHARACTERIZATION OF VARIANTS IP LYS-57; LYS-90 DEL AND TRP-123</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-113</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="J. Allergy Clin. Immunol." volume="113" first="725" last="733">
<title>The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.</title>
<authorList>
<person name="Orange J.S."/>
<person name="Jain A."/>
<person name="Ballas Z.K."/>
<person name="Schneider L.C."/>
<person name="Geha R.S."/>
<person name="Bonilla F.A."/>
</authorList>
<dbReference type="PubMed" id="15100680"/>
<dbReference type="DOI" id="10.1016/j.jaci.2004.01.762"/>
</citation>
<scope>VARIANTS EDAID1 ARG-153 AND ARG-417</scope>
<scope>VARIANT IMD33 TYR-417</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2004" name="J. Allergy Clin. Immunol." volume="114" first="650" last="656">
<title>Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.</title>
<authorList>
<person name="Orange J.S."/>
<person name="Levy O."/>
<person name="Brodeur S.R."/>
<person name="Krzewski K."/>
<person name="Roy R.M."/>
<person name="Niemela J.E."/>
<person name="Fleisher T.A."/>
<person name="Bonilla F.A."/>
<person name="Geha R.S."/>
</authorList>
<dbReference type="PubMed" id="15356572"/>
<dbReference type="DOI" id="10.1016/j.jaci.2004.06.052"/>
</citation>
<scope>INVOLVEMENT IN IMD33</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2014" name="Cell. Signal." volume="26" first="2606" last="2613">
<title>TRIM13 regulates ubiquitination and turnover of NEMO to suppress TNF induced NF-kappaB activation.</title>
<authorList>
<person name="Tomar D."/>
<person name="Singh R."/>
</authorList>
<dbReference type="PubMed" id="25152375"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2014.08.008"/>
</citation>
<scope>INTERACTION WITH TRIM13</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2014" name="J. Virol." volume="88" first="10252" last="10258">
<title>Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon.</title>
<authorList>
<person name="Wang D."/>
<person name="Fang L."/>
<person name="Wei D."/>
<person name="Zhang H."/>
<person name="Luo R."/>
<person name="Chen H."/>
<person name="Li K."/>
<person name="Xiao S."/>
</authorList>
<dbReference type="PubMed" id="24920812"/>
<dbReference type="DOI" id="10.1128/jvi.00869-14"/>
</citation>
<scope>CLEAVAGE BY HAV PROTEASE 3C (MICROBIAL INFECTION)</scope>
<scope>CLEAVAGE SITES</scope>
<scope>MUTAGENESIS OF GLN-304</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2016" name="Nat. Immunol." volume="17" first="1373" last="1380">
<title>Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.</title>
<authorList>
<person name="Xing J."/>
<person name="Weng L."/>
<person name="Yuan B."/>
<person name="Wang Z."/>
<person name="Jia L."/>
<person name="Jin R."/>
<person name="Lu H."/>
<person name="Li X.C."/>
<person name="Liu Y.J."/>
<person name="Zhang Z."/>
</authorList>
<dbReference type="PubMed" id="27695001"/>
<dbReference type="DOI" id="10.1038/ni.3580"/>
</citation>
<scope>INTERACTION WITH TRIM29</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2006" name="J. Exp. Med." volume="203" first="1745" last="1759">
<title>X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.</title>
<authorList>
<person name="Filipe-Santos O."/>
<person name="Bustamante J."/>
<person name="Haverkamp M.H."/>
<person name="Vinolo E."/>
<person name="Ku C.-L."/>
<person name="Puel A."/>
<person name="Frucht D.M."/>
<person name="Christel K."/>
<person name="von Bernuth H."/>
<person name="Jouanguy E."/>
<person name="Feinberg J."/>
<person name="Durandy A."/>
<person name="Senechal B."/>
<person name="Chapgier A."/>
<person name="Vogt G."/>
<person name="de Beaucoudrey L."/>
<person name="Fieschi C."/>
<person name="Picard C."/>
<person name="Garfa M."/>
<person name="Chemli J."/>
<person name="Bejaoui M."/>
<person name="Tsolia M.N."/>
<person name="Kutukculer N."/>
<person name="Plebani A."/>
<person name="Notarangelo L."/>
<person name="Bodemer C."/>
<person name="Geissmann F."/>
<person name="Israeel A."/>
<person name="Veron M."/>
<person name="Knackstedt M."/>
<person name="Barbouche R."/>
<person name="Abel L."/>
<person name="Magdorf K."/>
<person name="Gendrel D."/>
<person name="Agou F."/>
<person name="Holland S.M."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="16818673"/>
<dbReference type="DOI" id="10.1084/jem.20060085"/>
</citation>
<scope>VARIANTS IMD33 ALA-315 AND GLN-319</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Hum. Mol. Genet." volume="16" first="2805" last="2815">
<title>Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.</title>
<authorList>
<person name="Sebban-Benin H."/>
<person name="Pescatore A."/>
<person name="Fusco F."/>
<person name="Pascuale V."/>
<person name="Gautheron J."/>
<person name="Yamaoka S."/>
<person name="Moncla A."/>
<person name="Ursini M.V."/>
<person name="Courtois G."/>
</authorList>
<dbReference type="PubMed" id="17728323"/>
<dbReference type="DOI" id="10.1093/hmg/ddm237"/>
</citation>
<scope>VARIANT IP PRO-323</scope>
<scope>CHARACTERIZATION OF VARIANT IP PRO-323</scope>
<scope>INTERACTION WITH TRAF6</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2010" name="J. Formos. Med. Assoc." volume="109" first="192" last="200">
<title>NEMO gene mutations in Chinese patients with incontinentia pigmenti.</title>
<authorList>
<person name="Hsiao P.F."/>
<person name="Lin S.P."/>
<person name="Chiang S.S."/>
<person name="Wu Y.H."/>
<person name="Chen H.C."/>
<person name="Lin Y.C."/>
</authorList>
<dbReference type="PubMed" id="20434027"/>
<dbReference type="DOI" id="10.1016/s0929-6646(10)60042-3"/>
</citation>
<scope>VARIANT IP HIS-183</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="Hum. Mutat." volume="35" first="165" last="177">
<title>Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.</title>
<authorList>
<person name="Conte M.I."/>
<person name="Pescatore A."/>
<person name="Paciolla M."/>
<person name="Esposito E."/>
<person name="Miano M.G."/>
<person name="Lioi M.B."/>
<person name="McAleer M.A."/>
<person name="Giardino G."/>
<person name="Pignata C."/>
<person name="Irvine A.D."/>
<person name="Scheuerle A.E."/>
<person name="Royer G."/>
<person name="Hadj-Rabia S."/>
<person name="Bodemer C."/>
<person name="Bonnefont J.P."/>
<person name="Munnich A."/>
<person name="Smahi A."/>
<person name="Steffann J."/>
<person name="Fusco F."/>
<person name="Ursini M.V."/>
</authorList>
<dbReference type="PubMed" id="24339369"/>
<dbReference type="DOI" id="10.1002/humu.22483"/>
</citation>
<scope>VARIANTS IP PRO-170; GLN-173; PRO-314; PRO-322 AND TYR-413</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2007" name="J. Med. Genet." volume="44" first="16" last="23">
<title>IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.</title>
<authorList>
<person name="Ku C.-L."/>
<person name="Picard C."/>
<person name="Erdos M."/>
<person name="Jeurissen A."/>
<person name="Bustamante J."/>
<person name="Puel A."/>
<person name="von Bernuth H."/>
<person name="Filipe-Santos O."/>
<person name="Chang H.-H."/>
<person name="Lawrence T."/>
<person name="Raes M."/>
<person name="Marodi L."/>
<person name="Bossuyt X."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="16950813"/>
<dbReference type="DOI" id="10.1136/jmg.2006.044446"/>
</citation>
<scope>VARIANT IMD33 GLY-173</scope>
</reference>
<comment type="function">
<text evidence="27 48 52">Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin seems to play a role in IKK activation by multiple signaling receptor pathways. However, the specific type of polyubiquitin recognized upon cell stimulation (either 'Lys-63'-linked or linear polyubiquitin) and its functional importance is reported conflictingly. Also considered to be a mediator for TAX activation of NF-kappa-B. Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3. Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="8 15 18 19 21 23 25 28 32 34 35 39 40 41 42 44 56 57 58 62 63 64 65">Homodimer; disulfide-linked. Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65. Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Interacts with COPS3, CYLD, NALP2, TRPC4AP and PIDD1. Interacts with ATM; the complex is exported from the nucleus. Interacts with TRAF6. Interacts with IKBKE. Interacts with TANK; the interaction is enhanced by IKBKE and TBK1. Part of a ternary complex consisting of TANK, IKBKB and IKBKG. Interacts with ZFAND5. Interacts with RIPK2. Interacts with TNIP1 and TNFAIP3; TNIP1 facilitates the TNFAIP3-mediated de-ubiquitination of IKBKG. Interacts with TNFAIP3; the interaction is induced by TNF stimulation and by polyubiquitin. Binds polyubiquitin; the interaction is mediated by two domains; reports about the binding to 'Lys-63'-linked and/or linear polyubiquitin, respective binding affinities and stoichiometry are conflicting. Interacts with NLRP10. Interacts with TANK; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with USP10; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with ZC3H12A; this interaction increases in response to DNA damage (PubMed:25861989). Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation (PubMed:26334375). Interacts with TRIM29; this interaction induces IKBKG/NEMO ubiquitination and proteolytic degradation (PubMed:27695001). Interacts with TRIM13; this interaction leads to IKBKG/NEMO ubiquitination (PubMed:25152375). Interacts with ARFIP2 (PubMed:26296658). Interacts with RIPK1 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="66">(Microbial infection) Interacts with Molluscum contagiosum virus protein MC005; this interaction inhibits NF-kappa-B activation.</text>
</comment>
<comment type="subunit">
<text evidence="11 14">(Microbial infection) Interacts with HTLV-1 Tax oncoprotein; the interaction activates IKBKG.</text>
</comment>
<comment type="subunit">
<text evidence="50">(Microbial infection) Interacts with Shigella flexneri ipah9.8; the interaction promotes TNIP1-dependent 'Lys-27'-linked polyubiquitination of IKBKG which perturbs NF-kappa-B activation during bacterial infection.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-718895">
<id>Q9NPF8</id>
<label>ADAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-2511319">
<id>Q4VCS5</id>
<label>AMOT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-354007">
<id>P04083</id>
<label>ANXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-2683099">
<id>Q66PJ3</id>
<label>ARL6IP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-495465">
<id>Q13315</id>
<label>ATM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-968983">
<id>Q13535</id>
<label>ATR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-958922">
<id>O95999</id>
<label>BCL10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-4286943">
<id>P05937</id>
<label>CALB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-375096">
<id>P24941</id>
<label>CDK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-350590">
<id>Q9UNS2</id>
<label>COPS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-5453285">
<id>Q2TBE0</id>
<label>CWF19L2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-744099">
<id>Q9H0I2</id>
<label>ENKD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-3946257">
<id>P36888</id>
<label>FLT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-1046878">
<id>Q14161</id>
<label>GIT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-746309">
<id>Q92917</id>
<label>GPKOW</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-6163836">
<id>Q7Z4H3</id>
<label>HDDC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>35</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-297888">
<id>P05783</id>
<label>KRT18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-297852">
<id>P05787</id>
<label>KRT8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-739546">
<id>Q96PV6</id>
<label>LENG8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-1047372">
<id>Q9UDY8</id>
<label>MALT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-358011">
<id>Q99558</id>
<label>MAP3K14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-9057006">
<id>Q9UJX0</id>
<label>OSGIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-712311">
<id>P67775</id>
<label>PPP2CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-2798416">
<id>Q99633</id>
<label>PRPF18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-357828">
<id>P28074</id>
<label>PSMB5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-2340624">
<id>Q9BYM8</id>
<label>RBCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-358507">
<id>Q13546</id>
<label>RIPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-948111">
<id>Q96EP0</id>
<label>RNF31</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-398632">
<id>Q9UBF6</id>
<label>RNF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-6257338">
<id>Q9BVN2-2</id>
<label>RUSC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-714881">
<id>Q9HC62</id>
<label>SENP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-3942966">
<id>Q9H0F6</id>
<label>SHARPIN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-750559">
<id>O95391</id>
<label>SLU7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-632715">
<id>Q13573</id>
<label>SNW1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-307104">
<id>Q13501</id>
<label>SQSTM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-524909">
<id>P21579</id>
<label>SYT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-356349">
<id>Q92844</id>
<label>TANK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-359977">
<id>P01375</id>
<label>TNF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-527670">
<id>P21580</id>
<label>TNFAIP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-357849">
<id>Q15025</id>
<label>TNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-359372">
<id>Q8NFZ5</id>
<label>TNIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-745527">
<id>Q9Y2X8</id>
<label>UBE2D4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-747793">
<id>Q5D1E8</id>
<label>ZC3H12A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-6427977">
<id>Q96SQ5</id>
<label>ZNF587</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-5667516">
<id>Q9Y2P0</id>
<label>ZNF835</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
</interactant>
<interactant intactId="EBI-6125799">
<id>Q8VSC3</id>
<label>ipaH9.8</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="26">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Nucleus</location>
</subcellularLocation>
<text>Sumoylated NEMO accumulates in the nucleus in response to genotoxic stress.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6K9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6K9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041000"/>
</isoform>
<isoform>
<id>Q9Y6K9-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041001 VSP_041002"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.</text>
</comment>
<comment type="domain">
<text evidence="43 48">The leucine-zipper domain and the CCHC NOA-type zinc-finger are essential for polyubiquitin binding and for the activation of IRF3.</text>
</comment>
<comment type="PTM">
<text evidence="40">Phosphorylation at Ser-68 attenuates aminoterminal homodimerization.</text>
</comment>
<comment type="PTM">
<text evidence="26 27 33 46 50 53 62">Polyubiquitinated on Lys-285 through 'Lys-63'; the ubiquitination is mediated by NOD2 and RIPK2 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Polyubiquitinated on Lys-399 through 'Lys-63'; the ubiquitination is mediated by BCL10, MALT1 and TRAF6 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Monoubiquitinated on Lys-277 and Lys-309; promotes nuclear export. Polyubiquitinated through 'Lys-27' by TRIM23; involved in antiviral innate and inflammatory responses. Linear polyubiquitinated on Lys-111, Lys-143, Lys-226, Lys-246, Lys-264, Lys-277, Lys-285, Lys-292, Lys-302, Lys-309 and Lys-326; the head-to-tail polyubiquitination is mediated by the LUBAC complex and plays a key role in NF-kappa-B activation. Deubiquitinated by USP10 in a TANK-dependent and -independent manner, leading to the negative regulation of NF-kappa-B signaling upon DNA damage (PubMed:25861989).</text>
</comment>
<comment type="PTM">
<text evidence="26 35 46 50 53">Sumoylated on Lys-277 and Lys-309 with SUMO1; the modification results in phosphorylation of Ser-85 by ATM leading to a replacement of the sumoylation by mono-ubiquitination on these residues.</text>
</comment>
<comment type="PTM">
<text evidence="54">Neddylated by TRIM40, resulting in stabilization of NFKBIA and down-regulation of NF-kappa-B activity.</text>
</comment>
<comment type="PTM">
<text evidence="61">(Microbial infection) Cleaved by hepatitis A virus (HAV) protease 3C allowing the virus to disrupt the host innate immune signaling.</text>
</comment>
<comment type="PTM">
<text evidence="50">(Microbial infection) Polyubiquitinated on Lys-309 and Lys-321 via 'Lys-27'-linked ubiquitin by Shigella flexneri E3 ubiquitin-protein ligase ipah9.8, leading to its degradation by the proteasome.</text>
</comment>
<comment type="disease" evidence="13 16 17 22 26 29 36 47 55">
<disease id="DI-00424">
<name>Ectodermal dysplasia and immunodeficiency 1</name>
<acronym>EDAID1</acronym>
<description>A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. EDAID1 is an X-linked recessive disorder characterized by absence of sweat glands, sparse scalp hair, rare conical teeth and immunological abnormalities resulting in severe infectious diseases. Severely affected individuals may also show lymphedema, osteopetrosis, and, rarely, hematologic abnormalities. The phenotype is highly variable, and may be fatal in childhood.</description>
<dbReference type="MIM" id="300291"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="29 31 37 38 47 49">
<disease id="DI-02445">
<name>Immunodeficiency 33</name>
<acronym>IMD33</acronym>
<description>An X-linked recessive disorder characterized by variably impaired immunologic function and early-onset recurrent infections, usually due to pneumococcus, H. influenzae, and atypical mycobacteria. Features of hypohidrotic ectodermal dysplasia are generally not present, although some patients may have conical teeth or hypodontia.</description>
<dbReference type="MIM" id="300636"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12 20 30 39 45 51 60">
<disease id="DI-00597">
<name>Incontinentia pigmenti</name>
<acronym>IP</acronym>
<description>A genodermatosis usually prenatally lethal in males. In affected females, it causes abnormalities of the skin, hair, eyes, nails, teeth, skeleton, heart, and central nervous system. The prominent skin signs occur in four classic cutaneous stages: perinatal inflammatory vesicles, verrucous patches, a distinctive pattern of hyperpigmentation and dermal scarring.</description>
<dbReference type="MIM" id="308300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="IKBKGbase">
<link uri="http://structure.bmc.lu.se/idbase/IKBKGbase/"/>
<text>IKBKG mutation db</text>
</comment>
<comment type="online information" name="Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG)">
<link uri="http://databases.lovd.nl/shared/genes/IKBKG"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="AF062089">
<property type="protein sequence ID" value="AAD12183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF091453">
<property type="protein sequence ID" value="AAD38081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF074382">
<property type="protein sequence ID" value="AAC36330.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ271718">
<property type="protein sequence ID" value="CAB93146.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF261086">
<property type="protein sequence ID" value="AAF99679.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY114157">
<property type="protein sequence ID" value="AAM44073.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000593">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019621">
<property type="protein sequence ID" value="AAV38427.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277315">
<property type="protein sequence ID" value="AAL27012.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000299">
<property type="protein sequence ID" value="AAH00299.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012114">
<property type="protein sequence ID" value="AAH12114.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC046922">
<property type="protein sequence ID" value="AAH46922.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC050612">
<property type="protein sequence ID" value="AAH50612.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14757.1">
<molecule id="Q9Y6K9-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48196.1">
<molecule id="Q9Y6K9-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48197.1">
<molecule id="Q9Y6K9-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001093326.2">
<molecule id="Q9Y6K9-2"/>
<property type="nucleotide sequence ID" value="NM_001099856.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001093327.1">
<molecule id="Q9Y6K9-1"/>
<property type="nucleotide sequence ID" value="NM_001099857.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138727.1">
<molecule id="Q9Y6K9-3"/>
<property type="nucleotide sequence ID" value="NM_001145255.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308325.1">
<molecule id="Q9Y6K9-1"/>
<property type="nucleotide sequence ID" value="NM_001321396.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308326.1">
<property type="nucleotide sequence ID" value="NM_001321397.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003630.1">
<molecule id="Q9Y6K9-1"/>
<property type="nucleotide sequence ID" value="NM_003639.4"/>
</dbReference>
<dbReference type="PDB" id="2JVX">
<property type="method" value="NMR"/>
<property type="chains" value="A=394-419"/>
</dbReference>
<dbReference type="PDB" id="2JVY">
<property type="method" value="NMR"/>
<property type="chains" value="A=394-419"/>
</dbReference>
<dbReference type="PDB" id="3BRT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="B/D=44-111"/>
</dbReference>
<dbReference type="PDB" id="3BRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B/D=44-111"/>
</dbReference>
<dbReference type="PDB" id="3CL3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="D/E=150-272"/>
</dbReference>
<dbReference type="PDB" id="3FX0">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=246-337"/>
</dbReference>
<dbReference type="PDB" id="4BWN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A/B=258-344"/>
</dbReference>
<dbReference type="PDB" id="5AAY">
<property type="method" value="NMR"/>
<property type="chains" value="A=392-419"/>
</dbReference>
<dbReference type="PDB" id="5LDE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.38"/>
<property type="chains" value="R/S=230-249"/>
</dbReference>
<dbReference type="PDB" id="6MI3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A/B=38-129"/>
</dbReference>
<dbReference type="PDB" id="6MI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=38-129"/>
</dbReference>
<dbReference type="PDBsum" id="2JVX"/>
<dbReference type="PDBsum" id="2JVY"/>
<dbReference type="PDBsum" id="3BRT"/>
<dbReference type="PDBsum" id="3BRV"/>
<dbReference type="PDBsum" id="3CL3"/>
<dbReference type="PDBsum" id="3FX0"/>
<dbReference type="PDBsum" id="4BWN"/>
<dbReference type="PDBsum" id="5AAY"/>
<dbReference type="PDBsum" id="5LDE"/>
<dbReference type="PDBsum" id="6MI3"/>
<dbReference type="PDBsum" id="6MI4"/>
<dbReference type="BMRB" id="Q9Y6K9"/>
<dbReference type="SMR" id="Q9Y6K9"/>
<dbReference type="BioGRID" id="114089">
<property type="interactions" value="394"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3269">
<property type="entry name" value="IkappaB kinase complex"/>
</dbReference>
<dbReference type="CORUM" id="Q9Y6K9"/>
<dbReference type="DIP" id="DIP-27528N"/>
<dbReference type="IntAct" id="Q9Y6K9">
<property type="interactions" value="242"/>
</dbReference>
<dbReference type="MINT" id="Q9Y6K9"/>
<dbReference type="STRING" id="9606.ENSP00000483825"/>
<dbReference type="BindingDB" id="Q9Y6K9"/>
<dbReference type="ChEMBL" id="CHEMBL4967"/>
<dbReference type="DrugBank" id="DB04998">
<property type="generic name" value="AGRO100"/>
</dbReference>
<dbReference type="DrugBank" id="DB05289">
<property type="generic name" value="Tarenflurbil"/>
</dbReference>
<dbReference type="MoonDB" id="Q9Y6K9">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9Y6K9"/>
<dbReference type="PhosphoSitePlus" id="Q9Y6K9"/>
<dbReference type="BioMuta" id="IKBKG"/>
<dbReference type="DMDM" id="6685695"/>
<dbReference type="CPTAC" id="CPTAC-1044"/>
<dbReference type="CPTAC" id="CPTAC-806"/>
<dbReference type="EPD" id="Q9Y6K9"/>
<dbReference type="jPOST" id="Q9Y6K9"/>
<dbReference type="MassIVE" id="Q9Y6K9"/>
<dbReference type="PaxDb" id="Q9Y6K9"/>
<dbReference type="PeptideAtlas" id="Q9Y6K9"/>
<dbReference type="PRIDE" id="Q9Y6K9"/>
<dbReference type="ProteomicsDB" id="86716">
<molecule id="Q9Y6K9-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86717">
<molecule id="Q9Y6K9-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86718">
<molecule id="Q9Y6K9-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="73338">
<property type="antibodies" value="1214 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="8517"/>
<dbReference type="Ensembl" id="ENST00000594239">
<molecule id="Q9Y6K9-1"/>
<property type="protein sequence ID" value="ENSP00000471166"/>
<property type="gene ID" value="ENSG00000269335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000611071">
<molecule id="Q9Y6K9-1"/>
<property type="protein sequence ID" value="ENSP00000479662"/>
<property type="gene ID" value="ENSG00000269335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000611176">
<molecule id="Q9Y6K9-3"/>
<property type="protein sequence ID" value="ENSP00000478616"/>
<property type="gene ID" value="ENSG00000269335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000618670">
<molecule id="Q9Y6K9-2"/>
<property type="protein sequence ID" value="ENSP00000483825"/>
<property type="gene ID" value="ENSG00000269335"/>
</dbReference>
<dbReference type="GeneID" id="8517"/>
<dbReference type="KEGG" id="hsa:8517"/>
<dbReference type="UCSC" id="uc033fbu.1">
<molecule id="Q9Y6K9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8517"/>
<dbReference type="DisGeNET" id="8517"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000269335.5"/>
<dbReference type="GeneCards" id="IKBKG"/>
<dbReference type="GeneReviews" id="IKBKG"/>
<dbReference type="HGNC" id="HGNC:5961">
<property type="gene designation" value="IKBKG"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000269335">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="IKBKG"/>
<dbReference type="MIM" id="300248">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="300291">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300636">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="308300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6K9"/>
<dbReference type="OpenTargets" id="ENSG00000269335"/>
<dbReference type="Orphanet" id="69088">
<property type="disease" value="Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="98813">
<property type="disease" value="Hypohidrotic ectodermal dysplasia with immunodeficiency"/>
</dbReference>
<dbReference type="Orphanet" id="464">
<property type="disease" value="Incontinentia pigmenti"/>
</dbReference>
<dbReference type="Orphanet" id="319612">
<property type="disease" value="X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29777"/>
<dbReference type="eggNOG" id="ENOG502R4ZD">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063808"/>
<dbReference type="InParanoid" id="Q9Y6K9"/>
<dbReference type="KO" id="K07210"/>
<dbReference type="OMA" id="AHPSFHL"/>
<dbReference type="OrthoDB" id="745047at2759"/>
<dbReference type="PhylomeDB" id="Q9Y6K9"/>
<dbReference type="TreeFam" id="TF326608"/>
<dbReference type="PathwayCommons" id="Q9Y6K9"/>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168927">
<property type="pathway name" value="TICAM1, RIP1-mediated IKK complex recruitment"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450302">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450321">
<property type="pathway name" value="JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4755510">
<property type="pathway name" value="SUMOylation of immune response proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357905">
<property type="pathway name" value="Regulation of TNFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602636">
<property type="pathway name" value="IKBKB deficiency causes SCID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603027">
<property type="pathway name" value="IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937039">
<property type="pathway name" value="IRAK1 recruits IKK complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975144">
<property type="pathway name" value="IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9Y6K9"/>
<dbReference type="SIGNOR" id="Q9Y6K9"/>
<dbReference type="BioGRID-ORCS" id="8517">
<property type="hits" value="42 hits in 502 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IKBKG">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y6K9"/>
<dbReference type="GeneWiki" id="IKBKG"/>
<dbReference type="GenomeRNAi" id="8517"/>
<dbReference type="Pharos" id="Q9Y6K9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y6K9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y6K9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000269335">
<property type="expression patterns" value="Expressed in blood and 114 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y6K9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y6K9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0008385">
<property type="term" value="C:IkappaB kinase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="LIFEdb"/>
</dbReference>
<dbReference type="GO" id="GO:0072686">
<property type="term" value="C:mitotic spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0070530">
<property type="term" value="F:K63-linked polyubiquitin modification-dependent protein binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990450">
<property type="term" value="F:linear polyubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042975">
<property type="term" value="F:peroxisome proliferator activated receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990459">
<property type="term" value="F:transferrin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043276">
<property type="term" value="P:anoikis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002479">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051650">
<property type="term" value="P:establishment of vesicle localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0065003">
<property type="term" value="P:protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043122">
<property type="term" value="P:regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010803">
<property type="term" value="P:regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="DisProt" id="DP02269"/>
<dbReference type="InterPro" id="IPR032419">
<property type="entry name" value="CC2-LZ_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021063">
<property type="entry name" value="NEMO_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR034735">
<property type="entry name" value="NEMO_ZF"/>
</dbReference>
<dbReference type="Pfam" id="PF16516">
<property type="entry name" value="CC2-LZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11577">
<property type="entry name" value="NEMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51801">
<property type="entry name" value="ZF_CCHC_NOA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0038">Ectodermal dysplasia</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0987">Osteopetrosis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="NF-kappa-B essential modulator" id="PRO_0000096782">
<location>
<begin position="1"/>
<end position="419"/>
</location>
</feature>
<feature type="zinc finger region" description="CCHC NOA-type" evidence="10">
<location>
<begin position="389"/>
<end position="419"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CHUK/IKBKB">
<location>
<begin position="44"/>
<end position="111"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TANK">
<location>
<begin position="150"/>
<end position="257"/>
</location>
</feature>
<feature type="region of interest" description="Ubiquitin-binding (UBD)">
<location>
<begin position="242"/>
<end position="350"/>
</location>
</feature>
<feature type="region of interest" description="Self-association">
<location>
<begin position="246"/>
<end position="365"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with TNFAIP3">
<location>
<begin position="251"/>
<end position="419"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper" evidence="9">
<location>
<begin position="322"/>
<end position="343"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CYLD" evidence="25">
<location>
<begin position="382"/>
<end position="419"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="9">
<location>
<begin position="49"/>
<end position="356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="24">
<location>
<position position="31"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="24">
<location>
<position position="43"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="40">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="35">
<location>
<position position="85"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="24">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 59">
<location>
<position position="387"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="42">
<location>
<position position="54"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="42">
<location>
<position position="347"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="111"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="139"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="143"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="226"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="246"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="264"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="26">
<location>
<position position="277"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="26 53">
<location>
<position position="277"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="283"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33 46 53">
<location>
<position position="285"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="292"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="302"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="26">
<location>
<position position="309"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="26 46 50 53">
<location>
<position position="309"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="50">
<location>
<position position="321"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="325"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="53">
<location>
<position position="326"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="27">
<location>
<position position="399"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041000" evidence="68">
<original>M</original>
<variation>MALVIQVGKLRPREVRTPQTINPSLFPSLPVKLSSIIEVPSGGERCCSRRTLVYKARAFWKGAPLPCWM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041001" evidence="67">
<location>
<begin position="174"/>
<end position="224"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041002" evidence="67">
<location>
<begin position="257"/>
<end position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; shows the same luciferase activity as the control; dbSNP:rs148695964." id="VAR_026491" evidence="20 30">
<original>E</original>
<variation>K</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; only 46.3% of the activation obtained with the wild-type protein." id="VAR_026492" evidence="30">
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs179363896." id="VAR_026493" evidence="30">
<original>D</original>
<variation>N</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; shows the same luciferase activity as the control; dbSNP:rs179363895." id="VAR_026494" evidence="30">
<original>R</original>
<variation>W</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs137853328." id="VAR_026495" evidence="22 29">
<original>L</original>
<variation>R</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In IP." id="VAR_072603" evidence="60">
<original>L</original>
<variation>P</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD33; dbSNP:rs179363866." id="VAR_031958" evidence="38">
<original>R</original>
<variation>G</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; dbSNP:rs1057520292." id="VAR_072604" evidence="60">
<original>R</original>
<variation>Q</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs179363868." id="VAR_011320" evidence="17">
<original>R</original>
<variation>P</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; dbSNP:rs1198984417." id="VAR_072605" evidence="51">
<original>Q</original>
<variation>H</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs179363869." id="VAR_011321" evidence="17">
<original>L</original>
<variation>P</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs137853330." id="VAR_011322" evidence="17">
<original>A</original>
<variation>G</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; abolishes binding to polyubiquitin ('K63'-linked and linear) and greatly impairs tandem ubiquitin binding; dbSNP:rs179363867." id="VAR_011323" evidence="17 36 47 55">
<original>D</original>
<variation>N</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In IP." id="VAR_072606" evidence="60">
<original>A</original>
<variation>P</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD33; greatly impairs tandem ubiquitin binding. Impairs oligomerization, impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin, impairs TNF-induced NF-kappa-B activation; dbSNP:rs137853331." id="VAR_031959" evidence="37 47 49">
<original>E</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD33; impairs tandem ubiquitin binding; dbSNP:rs137853332." id="VAR_031960" evidence="37 47">
<original>R</original>
<variation>Q</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In IP." id="VAR_072607" evidence="60">
<original>L</original>
<variation>P</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; diminishes interaction with TRAF6 and polyubiquitination, greatly impairs tandem ubiquitin binding. Impairs oligomerization, greatly impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin, impairs TNF-induced NF-kappa-B activation; dbSNP:rs179363865." id="VAR_042666" evidence="39 47 49">
<original>A</original>
<variation>P</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs137853327." id="VAR_011324" evidence="16">
<original>D</original>
<variation>V</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In IP; impairs binding to ubiquitin; dbSNP:rs137853322." id="VAR_009182" evidence="12 20 45">
<original>M</original>
<variation>V</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In IP." id="VAR_072608" evidence="60">
<original>H</original>
<variation>Y</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; dbSNP:rs137853326." id="VAR_011325" evidence="13 17">
<original>C</original>
<variation>F</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In EDAID1; loss of sumoylation; dbSNP:rs137853325." id="VAR_011326" evidence="13 16 17 22 26 29">
<original>C</original>
<variation>R</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD33; dbSNP:rs137853326." id="VAR_026496" evidence="29">
<original>C</original>
<variation>Y</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases formation of homodimers." evidence="40">
<original>S</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with IKBKB; abolishes TNF-alpha induced NF-kappa-B activity." evidence="40">
<original>S</original>
<variation>E</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ubiquitination and abolishes nuclear export." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in the ubiquitination level; when associated with R-399." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in the ubiquitination level; when associated with R-399." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial abolition of sumoylation. Abolishes sumoylation and IKK activation; when associated with A-309." evidence="26">
<original>K</original>
<variation>A</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="Important decrease in the ubiquitination level; when associated with R-399." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effet on oligomerization,impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin, impairs TNF-induced NF-kappa-B activation." evidence="49">
<original>E</original>
<variation>A</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="47">
<original>V</original>
<variation>D</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs tandem ubiquitin binding." evidence="47">
<original>L</original>
<variation>A</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by HAV protease 3c." evidence="61">
<original>Q</original>
<variation>A</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs tandem ubiquitin binding." evidence="47">
<original>Q</original>
<variation>A</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="47">
<original>I</original>
<variation>N</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="47">
<original>Y</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial abolition of sumoylation. Abolishes sumoylation and IKK activation; when associated with A-277." evidence="26">
<original>K</original>
<variation>A</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding,impairs oligomerization, impairs TNF-induced NF-kappa-B activation." evidence="47 49">
<original>F</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="MNo effet on oligomerization, preferentially binds tri-ubiquitin chains ('Lys-48' or 'Lys-63'-linked)." evidence="47 49">
<original>F</original>
<variation>W</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs tandem ubiquitin binding." evidence="47 49">
<original>F</original>
<variation>Y</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs tandem ubiquitin binding." evidence="47">
<original>Q</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="49">
<original>E</original>
<variation>Q</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="47">
<original>Q</original>
<variation>A</variation>
<variation>W</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs tandem ubiquitin binding." evidence="49">
<original>A</original>
<variation>D</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs oligomerization, impairs binding of 'Lys-63'-linked ubiuitin, impairs TNF-induced NF-kappa-B activation; when associated with A-336." evidence="36 49">
<original>L</original>
<variation>A</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to polyubiquitin." evidence="36 49">
<original>L</original>
<variation>P</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs oligomerization, impairs binding of 'Lys-63'-linked ubiuitin, impairs TNF-induced NF-kappa-B activation; when associated with A-329." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes BCL10-mediated but not RIPK2-mediated ubiquitination. Important decrease in the ubiquitination level; when associated with R-285. No change in the ubiquitination level; when associated with R-115 or R-224." evidence="27 33">
<original>K</original>
<variation>R</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to polyubiquitin." evidence="45">
<original>V</original>
<variation>S</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to polyubiquitin." evidence="45">
<original>M</original>
<variation>S</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD12183." ref="1" evidence="69">
<original>S</original>
<variation>R</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD12183." ref="1" evidence="69">
<original>S</original>
<variation>R</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="38"/>
<end position="129"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="194"/>
<end position="196"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="197"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="260"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="271"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="297"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="394"/>
<end position="396"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="403"/>
<end position="406"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="407"/>
<end position="416"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JVX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JVY"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CL3"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BWN"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AAY"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6MI3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88522"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01142"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10364167"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10839543"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11047757"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11064457"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11080499"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11224521"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11242109"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389905"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11418127"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11590134"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12045264"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12133833"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12657630"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917691"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14651848"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14695475"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14754897"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15100680"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15229184"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15356572"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456791"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15620648"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16360037"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16497931"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16547522"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818673"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16950813"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17728323"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17977820"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18079694"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18164680"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18313693"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18462684"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19033441"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19136968"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19185524"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19854139"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19854204"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20010814"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20434027"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20724660"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21455181"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21474709"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21606507"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22099304"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22672233"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453969"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24012789"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24339369"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24920812"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25861989"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26296658"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26334375"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27695001"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28490597"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="69" type="ECO:0000305"/>
<sequence length="419" mass="48198" checksum="322D1037881447FF" modified="2000-05-30" version="2">MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

